Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.16 USD | -1.21% |
|
-5.88% | -3.32% |
Jun. 13 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
Jun. 13 | Voyager Therapeutics, Inc. Appoints Nathan Jorgensen as Chief Financial Officer, Effective July 8, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.32% | 444M | |
+34.01% | 51.07B | |
+33.31% | 38.86B | |
-8.02% | 38.78B | |
-11.12% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Transcript : Voyager Therapeutics, Inc., Q4 2022 Earnings Call, Mar 07, 2023